1-Boc-哌啶甲酸酰肼，CAS 登记号 625470-88-4，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 1-Boc-哌啶甲酸酰肼 的 CAS 号：625470-88-4，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
1-Boc-Nipecotic acid hydrazide · CAS 625470-88-4 · C11H21N3O3.
| CAS Registry Number | 625470-88-4 |
|---|---|
| PubChem CID | 45158811 |
| Molecular formula | C11H21N3O3 |
| IUPAC name | tert-butyl 3-(hydrazinecarbonyl)piperidine-1-carboxylate |
| Molecular Weight | 243.30 |
|---|---|
| XLogP3 | 0.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 243.15829154 |
| Monoisotopic Mass | 243.15829154 |
| Topological Polar Surface Area | 84.7 |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Reported hazard statements | H302 (100%), H315 (100%), H319 (100%), H335 (100%) |
|---|
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
tert-butyl 3-(hydrazinecarbonyl)piperidine-1-carboxylate; 859154-32-8; RefChem:893100; 820-799-7; 1-Boc-Nipecotic acid hydrazide; 625470-88-4; MFCD06795929; tert-Butyl 3-(Hydrazinocarbonyl)piperidine-1-carboxylate; tert-Butyl3-(hydrazinecarbonyl)piperidine-1-carboxylate; (S)-1-Boc-piperidine-3-carbohydrazide; 1-Boc-3-(hydrazinecarbonyl)piperidine; SCHEMBL2730887; AKOS005072112; PB34581; SB20822; EN300-113059
CAS 625470-88-4; molecular formula C11H21N3O3; molecular weight — g/mol.
tert-butyl 3-(hydrazinecarbonyl)piperidine-1-carboxylate, 859154-32-8, RefChem:893100, 820-799-7, 1-Boc-Nipecotic acid hydrazide, 625470-88-4.
Hazard statements reported: H302, H315, H319, H335.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.